A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function
Clinical trial NCT02524717 · COMPLETED
Trial details
- NCT number
- NCT02524717
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-13
- Primary completion
- 2017-02-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.